The company, which is developing cancer treatments, plans to trade on the Nasdaq Global Market.
{iframe}https://www.bizjournals.com/washington/news/2021/01/20/gaithersburg-biotech-neximmune-files-for-ipo.amp.html{/iframe}
About BioHealth Innovation
BioHealth Innovation, Inc. (BHI) is an innovation intermediary that translates market-relevant research into commercial success by connecting management, funding, and markets.
Connect
© 2025 BioHealth Innovation.